卵巢癌与其他恶性肿瘤一样,人们长久以来努力在寻找其特有成分及肿瘤标记物,以期达到早期诊断、鉴别诊断、追踪监测、疗效观察及判断预后等目的。但卵巢癌确诊时多已属晚期,病死率为妇科恶性肿瘤首位。因此,其标记物就显得更为重要。肿瘤标记物是肿瘤细胞异常表达所产生的抗原和生物活性物质,在正常组织或良性疾病几乎不产生或产量甚微,它反映了 Ovarian cancer, like other malignancies, has long been trying to find its unique components and tumor markers in order to achieve the purpose of early diagnosis, differential diagnosis, follow-up monitoring, curative effect observation and prognosis. However, the diagnosis of ovarian cancer is more late, mortality was the first gynecological cancer. Therefore, the marker becomes even more important. Tumor markers are the antigens and biologically active substances produced by the abnormal expression of tumor cells. In normal tissues or benign diseases, almost no or little yield is produced, which reflects